13F

Stock

Allogene Therapeutics, Inc.

ALLO · held by 2 managers

Reported value

$957.4K

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$439.3K

Price effect on 2 books still in the name

Largest holder

$956.9K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC655.4K$956.9K−$439.1KCut−$664.7K
Leonteq Securities AG351$512−$236Cut−$236

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.